Results 101 to 110 of about 5,729,125 (133)
The study aimed to test the role of three Src‐family kinases, Hck, Fgr, and Lyn in immune complex glomerulonephritis. Hck, Fgr, and Lyn were overexpressed in human lupus nephritis and mouse nephrotoxic nephritis. Combined genetic deficiency of the three kinases practically completely protected mice from nephrotoxic nephritis.
Lukács S. Lesinszki +6 more
wiley +1 more source
Objective To investigate the expression pattern of sialic acid-binding immunoglobulin-like lectin 15 (Siglec- 15) in laryngeal squamous cell carcinoma (LSCC) and its correlation with clinical characteristics.
DU Qilong +6 more
doaj +1 more source
Aberrant glycosylation, especially sialylation, on cell surface is often associated with cancer progression and immunosuppression. Over-sialylation of stage-specific embryonic antigen-4 (SSEA-4) to generate disialylGb5 (DSGb5) was reported to trigger ...
Kuo-Shiang Liao +10 more
doaj +1 more source
ST6GAL1 sialylates glycoconjugates in the Golgi, modulating immune recognition and enabling tumor immune evasion. To effectively reach ST6GAL1, inhibitors should demonstrate good membrane permeability. Based on nonpermeable hit JFD 00458, we developed sulfonylurea analogs achieving increased membrane permeability and potency.
Natan Koraj +9 more
wiley +1 more source
Siglec-1 (cd169) expresszió vizsgálata monocyta alosztályokon gyulladásos myopathiákban
Absztrakt Háttér: Az idiopathias inflammatorikus myopathiák (IIM) szisztémás autoimmun betegségek, különböző klinikai megjelenési formákkal és patomechanizmusokkal. Ezen betegségekben az interferon útvonal az egyik fontos terápiás célpontok egyike.
Kun, Zsuzsanna Bella
core
Breast cancer (BRCA) is among the most prevalent cancers and is responsible for numerous patient fatalities. Immunotherapy has emerged as a promising approach to cancer treatment.
Huan Lai +5 more
doaj +1 more source
Siglec 15 as a biomarker or a druggable molecule for non-small cell lung cancer. [PDF]
Moreira RS +8 more
europepmc +1 more source
Siglec-15 is a glyco-immune checkpoint in prostate cancer regulating immune evasion and metastasis
Prostate cancer is a leading cause of cancer-related mortality in men, and effective treatment options are limited for advanced and metastatic disease. The sialoglycan immune checkpoint Siglec-15 has emerged as a key mediator of tumour-associated immune ...
David B Sykes +15 more
core +1 more source
Expression feature and prognostic function of a novel immune checkpoint Siglec-15 in human colorectal cancer [PDF]
Background. Sialic acid-bound immuno-globulin lectin 15 (Siglec-15) plays an important role in the development of cancer. However, the association between Siglec-15 expression and clinicopathological characteristics of colorectal cancer (CRC) has not ...
Xu, Li +7 more
core
Tumor-associated macrophages: untapped molecular targets to improve T cell-based immunotherapy
T cell responses are generally curtailed by suppressive mechanisms within the tumor microenvironment (TME) that prevent T cell infiltration and function.
Rui M. L. Coelho +2 more
doaj +1 more source

